Therapeutic archive
ISSN 0040-3660 (Print)
ISSN 2309-5342 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Home
>
Search
>
Author Details
Author Details
Khoroshko, N D
Issue
Section
Title
File
Vol 79, No 7 (2004)
Editorial
Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias
Vol 79, No 7 (2004)
Editorial
Molecular-cytogenetic monitoring of different regimens of treatment
Vol 79, No 7 (2004)
Editorial
Prediction of interferon therapy efficacy in chronic myeloid leukemia according to histomorphological evidence
Vol 79, No 7 (2004)
Editorial
Glivek in therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome
Vol 81, No 7 (2009)
Editorial
Trisomy of chromosome 8 in Ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of BCR-ABL tyrosinkinases
Vol 81, No 7 (2009)
Editorial
Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
Vol 82, No 12 (2010)
Editorial
Study of bone marrow microvessel density is one of the diagnostic approaches in patients with Ph-negative chronic myeloproliferative diseases
Vol 84, No 4 (2012)
Editorial
CHARACTERISTICS OF DIAGNOSTIC APPROACH TO ERYTHROCYTOSIS OF DIFFERENT GENESIS
Vol 78, No 7 (2003)
Editorial
Invasive aspergillesis in immunocompromised patients
Vol 78, No 8 (2003)
Editorial
Therapeutic efficacy of imatinibmesilate (glivek) in chronic phase of myeloid leukemia
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP